Filter Results:
(484)
Show Results For
- All HBS Web (484)
- Faculty Publications (183)
Show Results For
- All HBS Web (484)
- Faculty Publications (183)
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
As a senior at Hamilton College, I debated what career path to take. Should I go to Medical School? Maybe get a PhD? Or should I dive straight into the business world? I was a Biology major with four years of lab research under my belt. I... View Details
- 15 Dec 2014
- Research & Ideas
Deconstructing the Price Tag
When a company sets a price for a product, shoppers typically have no idea what it costs to produce that item. But it turns out that consumers reward efforts to lay out these figures—to deconstruct the price tag. In fact, new research... View Details
- 26 Jan 2009
- Research & Ideas
Where is Home for the Global Firm?
example, the fragmentation of production around the world, distribution outlets worldwide, and research and development facilities that capitalize on local talent pools. But we still basically think that firms belong to some home country... View Details
Keywords: by Martha Lagace
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
technologies for drug discovery.) And patients with previously unmet medical needs can now get treatments that were not available before. That should be inspiring, he reminded the audience. Economic frustrations remain, however. Pisano cautioned that current data on... View Details
- 10 Jun 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Cofounders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
The corporate histories of Apple, Coca-Cola, and Honda are well-documented stories that offer a window into the nuances of business in a particular place, at a particular time. As such, they're invaluable resources for research that... View Details
Keywords: by Julia Hanna
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's... View Details
- 02 Oct 2000
- Research & Ideas
The Dubious Logic of Global Megamergers
The assumption that industries will become more concentrated as they become more global, that the global economy is a winner-take-all economy, has become common wisdom. But, according to Pankaj Ghemawat and Fariborz Ghadar, empirical View Details
Keywords: by Pankaj Ghemawat & Fariborz Ghadar
- 07 Aug 2009
- What Do You Think?
Why Can’t Americans Get Health Care Right?
above are numerous in a channel that includes, in your comments, food and tobacco producers of unhealthy products (Christy Hitchens, Tom Dolembo); lifestyle equipment and service providers; developers and manufacturers of high-cost View Details
- 26 Sep 2006
- First Look
First Look: September 26, 2006
negative relation between this measure and both future stock returns and future profitability. The economic and statistical significance of our results is stronger than in previous research focusing on individual categories of corporate... View Details
Keywords: Sean Silverthorne
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
- December 2017 (Revised January 2018)
- Case
Alltech
By: David E. Bell and Natalie Kindred
Alltech was a Lexington, Kentucky–based producer of supplements for animal feed, with revenues of over $2 billion (projected to reach $3 billion in 2018), sales in 120 countries, 5,000 employees, and 100 manufacturing plants worldwide. For nearly four decades, Alltech... View Details
Keywords: Alltech; United States; Agribusiness; Agriculture; Animal; Animal Agriculture; Animal Feed; Livestock; Family Business; Vertical Integration; Strategy; Growth; Feed Additives; Feed Supplements; Kentucky; Growth Strategy; Family Businesses; Animal-Based Agribusiness; Acquisition; Business Growth and Maturation; Business Model; Change Management; Trends; Governance; Entrepreneurship; Growth and Development; Intellectual Property; Leadership; Management; Markets; Organizational Culture; Private Ownership; Science; Quality; Risk and Uncertainty; Research; Sales; Pharmaceutical Industry; Pharmaceutical Industry; United States; Kentucky; Brazil; China
Bell, David E., and Natalie Kindred. "Alltech." Harvard Business School Case 518-001, December 2017. (Revised January 2018.)
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
If you are one of the 17 million people who participated in the Ice Bucket Challenge a couple of summers ago, the money you helped raise to support ALS research may be at work today in a late-stage biopharmaceutical company headed by... View Details
Keywords: Deborah Blagg
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
facilities each year, an increasing number of which are on foreign soil. "Without the FDA, each of us would individually spend a lot more time researching where products come from and what ingredients they contain," says Harvard Business... View Details
- 07 Oct 2014
- First Look
First Look: October 7
management task in all innovating organizations. In this paper, we focus on the evaluation of frontier scientific research projects. We argue that the "intellectual distance" between the knowledge embodied in View Details
Keywords: Sean Silverthorne
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details
Keywords: Martha Lagace
- Web
Lessons from History - Creating Emerging Markets
Conferences Lessons from History Lessons from History Video Clips & Discussion Questions Resources on Indian Business History The Harvard Business School Creating Emerging Markets project (CEM), in collaboration with the HBS India View Details
- 01 Jun 2000
- News
The Business of Biotech
business and commercial development at Millennium Pharmaceuticals in Cambridge, Massachusetts. "It will revolutionize how medicine is practiced," he states simply. "Right now the doctor listens to your heart with a stethoscope and maybe... View Details
Keywords: Julia Hanna
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 06 Mar 2012
- First Look
First Look: March 6
learning, can reorient research about the link between identity-group-based diversity and performance. How to Make Finance Work Authors:Robin Greenwood and David S. Scharfstein Publication:Harvard Business Review 90, no. 3 (March 2012)... View Details
Keywords: Sean Silverthorne